Cardiovascular Disease
Cardiovascular disease (CVD) is a broad term encompassing various diseases of the heart and blood vessels, including coronary artery disease, heart failure, hypertensive heart disease, and more. Atherosclerotic CVD (ASCVD), the most common subtype, often leads to strokes and heart attacks.
Health Outcomes
- Altered Circulating Metabolic Profile
- Altered Fatty Acid Profiles
- Change in Waist-to-Hip Ratio
- Changed Leukocyte Telomere Length
- Changed Plasma Glycerophospholipid Levels
- Controlled Serum Cholesterol Levels
- Decreased Uncarboxylated to Total Osteocalcin Ratio
- Delayed Cardiac Pathology
- Developed Endocarditis
- Disease Prevention
- Elevated Malondialdehyde Levels
- Elevated Plasma-Branched Chain Amino Acids
- Elevated Redox Status
- Elevated Serum Leptin Levels
- Elevated Serum Lipoprotein Lipase Levels in Gilts
- Elevated Triglyceride Levels
- Enhanced AMPK Activation
- Enhanced Antioxidant Bioaccessibility
- Enhanced Antioxidant Capacity
- Enhanced Health Promotion
- Enhanced Reactive Oxygen Species Resistance
- Enhanced Reverse Cholesterol Transport
- Identified ACE-Inhibitory Peptides
- Improved 5000 m Running Time
- Improved Aerobic Power
- Improved Aerobic Stability
- Improved Antihypertensive Activity
- Improved Antioxidant Activity
- Improved Atherosclerosis-Related Cardiovascular Risk Markers
- Improved Bioactivity
- Improved Blood Biochemical Indicators
- Improved Blood Lipid Content
- Improved Blood Lipid Profile
- Improved Cardiometabolic Health
- Improved Cardiometabolic Score
- Improved Cardioprotective Activity
- Improved Cardiovascular Disease Marker
- Improved Cardiovascular Function
- Improved Cardiovascular Health
- Improved Cholesterol Levels
- Improved Cholesterol Metabolism
- Improved Cholesterol Profile
- Improved Cycling Endurance
- Improved Cycling Time Trial Performance
- Improved Diet Quality Index
- Improved Dyslipidemia
- Improved Endothelial Function Biomarker
- Improved Endothelial Health Marker Level
- Improved Endothelial Reactivity
- Improved Endothelium-Dependent Vasodilation in Resistance Arteries
- Improved Estimated VO2max
- Improved Event-Free Survival
- Improved Exercise Function
- Improved Exercise Stress Test Grade
- Improved Fatty Acid Composition
- Improved Fibrinolytic Activity
- Improved Fish Chemical Composition
- Improved Fitness in Breastfed Infants
- Improved Flow-Mediated Dilation
- Improved Flow-Mediated Vasodilation
- Improved Folate Levels
- Improved Functional Exercise Capacity
- Improved Global Health
- Improved Glutathione Level
- Improved Glutathione Peroxidase Activity
- Improved Glutathione Redox Ratio
- Improved Glycerophospholipid Metabolism
- Improved Health in Elderly Populations
- Improved Heart Rate Recovery
- Improved Heart Rate Variability
- Improved High-Density Lipoprotein Level
- Improved High-Intensity Intermittent Exercise Performance
- Improved Homeostasis
- Improved LDL-C to HDL-C Ratio
- Improved Lactate Threshold
- Improved Left Ventricular Ejection Fraction
- Improved Lifespan
- Improved Lipid Metabolism
- Improved Lipid Profile
- Improved Lipid Serum Homeostasis
- Improved Lipoprotein Subfraction Profile
- Improved Longevity
- Improved Low-Density Lipoprotein Composition
- Improved Maximal Oxygen Capacity
- Improved Maximal Oxygen Consumption
- Improved Mean Arterial Pressure
- Improved Metabolic Syndrome Biomarkers
- Improved Monocyte Activation
- Improved Myocardial Strain Rate
- Improved Obesity Parameters
- Improved Overall Health
- Improved Overall Health Status
- Improved Oxidative Metabolism Regulation
- Improved Oxidative Status
- Improved Oxidative Stress Marker
- Improved Peroxisome Proliferator-Activated Receptor Gamma Expression
- Improved Physical Activity Initiation
- Improved Physical Activity Level
- Improved Plasma Antioxidant Levels
- Improved Plasma Cholesterol Clearance
- Improved Plasma Lipid Levels
- Improved Prognosis of Type 2 Diabetes Mellitus
- Improved Proportion of Healthy Days
- Improved Reactive Hyperemia Index
- Improved Redox Homeostasis
- Improved Redox Potential
- Improved Retinal Microvascular Caliber
- Improved Retinal Vascular Health
- Improved Run Time
- Improved Running Endurance
- Improved Serum Averages
- Improved Serum Biochemistry
- Improved Serum Lipids
- Improved Serum Parameters
- Improved Serum SOD Activity
- Improved Stress-Strain Index
- Improved Superoxide Dismutase Activity
- Improved Superoxide Dismutase Level
- Improved Survival at 24 Months
- Improved Swimming Performance
- Improved Systemic Health
- Improved Time-Trial Performance
- Improved Total Cholesterol Levels
- Improved Triglyceride Levels
- Improved VO2 Max
- Improved VO2max
- Improved Vascular Endothelial Function
- Improved Vascular Function
- Improved Vitamin D Levels
- Improved Waist-to-Hip Ratio
- Improved Weight Control
- Improved Yo-Yo Test Performance
- Improved n-6 to n-3 PUFA Ratio
- Increased AMPK Activation
- Increased Adiponectin Levels
- Increased Antioxidant Potential
- Increased Apolipoprotein A-V Levels
- Increased Arginine/ADMA Ratio
- Increased Beneficial Gut Bacteria
- Increased Bioactivity
- Increased Bioavailability of Phenolics
- Increased Body Weight
- Increased Bone Marrow Myelopoiesis
- Increased Branched Chain Amino Acid Levels
- Increased CD68 to CD163 Ratio
- Increased Catalase Activity
- Increased Catalase Level
- Increased Circulating Vitamin K2 Levels
- Increased Complement C3 Level
- Increased Conjugated Linoleic Acid Production
- Increased Cysteine Level
- Increased Dietary Fiber Intake
- Increased Eicosapentaenoic Acid Level
- Increased Endogenous Acrolein Formation
- Increased Endurance Swimming Time
- Increased Exercise Endurance
- Increased F2-Isoprostane Level
- Increased FNDC5 Concentration
- Increased Ferric Reducing Ability of Plasma
- Increased Flavanone Metabolite Excretion
- Increased Folate Bioavailability
- Increased GSH/GSSG Ratio
- Increased General Morbidity
- Increased Glutathione Peroxidase Activity
- Increased HDL Cholesterol Levels
- Increased High-Density Lipoprotein Cholesterol
- Increased Homocysteine Level
- Increased Hormone-Sensitive Lipase Activity
- Increased Inhibition of Lipid Oxidation
- Increased KLF4 Protein Levels
- Increased LDL Cholesterol Level
- Increased Leptin Levels
- Increased Menaquinone-7 Levels
- Increased MicroRNA-146a Expression
- Increased Milk Alpha-Carotene Concentration
- Increased Mortality
- Increased Myeloperoxidase Activity
- Increased Naringenin Level
- Increased Nitric Oxide Bioavailability
- Increased Osteoprotegerin Immunostaining
- Increased Oxidative Stress
- Increased Paraoxonase 1 Enzyme Activity
- Increased Physical Activity
- Increased Plasma ApoA-V Levels
- Increased Plasma Omega-3 Fatty Acids
- Increased Plasma Vitamin K Levels
- Increased Plasminogen Activator Inhibitor-1 Level
- Increased Polyphenol Level
- Increased Polyunsaturated Fatty Acids in Breast Meat
- Increased Polyunsaturated Fatty Acids in Milk
- Increased Pro-inflammatory Cytokine IL-6
- Increased Production of ACE-Inhibitory Peptides
- Increased Production of Bioactive Peptides
- Increased Production of Bioactive Peptides with Angiotensin Converting Enzyme Inhibitory Activity
- Increased Reactive Oxygen Species Response
- Increased Serum Amyloid Protein
- Increased Serum High-Molecular Weight Adiponectin
- Increased Serum NAD+ Levels
- Increased Serum Triglycerides
- Increased Soluble Vascular Cell Adhesion Molecule-1 Level
- Increased Systolic Blood Pressure
- Increased Total Thiol Level
- Increased Triglyceride Level
- Increased VO2 Max
- Increased Viable Cell Antioxidant Activity
- Increased Visceral Fat Mass
- Induction of Browning of White Adipose Tissue
- Inhibited Lipid Oxidation
- Maintained High-Density Lipoprotein Levels
- Mitigated Cardiac Injury from Myocardial Infarction
- Modified Serum Metabolomic Pathways
- Modulated PPAR/SREBP Pathway
- Multiple Health-Promoting Effects
- No Adverse Health Effects
- No Change in Major Cardiovascular Event
- No Improvement in Total Cholesterol
- No Reduction in Meat Cholesterol Levels
- No Significant Change in Total Cholesterol
- No Significant Effect on C-Reactive Protein Levels
- Normalized Lipid Metabolism
- Normalized Lipid Profile
- Normalized Triglyceride
- Prevented Increase in Serum CML Levels
- Prevention of Hypercholesterolemia
- Prolonged Cardiac Allograft Survival
- Prolonged Survival Periods with Antiphospholipid Syndrome
- Reduced 25-Hydroxycholesterol Level
- Reduced 25-Hydroxycholesterol to Total Cholesterol Ratio
- Reduced 27-Hydroxycholesterol to Total Cholesterol Ratio
- Reduced 8-Isoprostane Level
- Reduced Abdominal Visceral Fat
- Reduced Acute Kidney Injury
- Reduced Advanced Glycation End Product Level
- Reduced Angiotensin I-Converting Enzyme Activity
- Reduced Aortic Inflammation
- Reduced Aortic Superoxide Levels
- Reduced Aortic Thickness
- Reduced Apelin Gene Expression
- Reduced Apo B to Apo A1 Ratio
- Reduced Apolipoprotein B Levels
- Reduced Apolipoprotein B to A-1 Ratio
- Reduced Apolipoprotein B-100
- Reduced Apolipoprotein B-100 to Apolipoprotein A-1 Ratio
- Reduced Apoptosis Signal-Regulating Kinase 1 Level
- Reduced Arachidonic Acid to EPA Ratio
- Reduced Arachidonic Acid/Eicosapentaenoic Acid Ratio
- Reduced Arterial Calcifying Lesion Development
- Reduced Arterial Stiffness
- Reduced Atherogenic Index
- Reduced Atherosclerosis Risk Factors
- Reduced Atherosclerotic Cardiovascular Disease Event
- Reduced Atherosclerotic Plaque Formation
- Reduced Atrial Fibrillation Risk
- Reduced Augmentation Index
- Reduced Blood Lipid Levels
- Reduced Blood Pressure in Offspring
- Reduced Body Fat
- Reduced C-Reactive Protein Levels
- Reduced Carboxymethyl Lysine
- Reduced Cardiac Event
- Reduced Cardiac Injury
- Reduced Cardiovascular Event
- Reduced Catalase Activity
- Reduced Cause-Specific Mortality
- Reduced Cellular Senescence
- Reduced Central Blood Pressure
- Reduced Cholesterol Metabolism
- Reduced Conicity Index
- Reduced Death Rate
- Reduced Dephosphorylated-Uncarboxylated Matrix Gla Protein Level
- Reduced Dietary Advanced Glycation End Product Intake
- Reduced Dyslipidemia Parameters
- Reduced Dyslipidemia in Metabolic Syndrome
- Reduced Exhaustion During Stress Test
- Reduced Fasting Insulin Level
- Reduced Ferroptosis
- Reduced Flavonifractor Abundance
- Reduced Flavonoid Levels
- Reduced Folate Deficiency
- Reduced Folic Acid Level
- Reduced Glutathione Loss
- Reduced Glycation End Product Accumulation
- Reduced Glycative Stress Marker Level
- Reduced HDL Cholesterol
- Reduced HDL Cholesterol Level
- Reduced HIF-1α Level
- Reduced HMG-CoA Reductase Inhibition
- Reduced Harmful Lipid Levels
- Reduced Heart Rate Variability
- Reduced Heat Stress
- Reduced High-Density Lipoprotein Cholesterol Level
- Reduced High-Sensitivity C-Reactive Protein Level
- Reduced Homocysteine Level
- Reduced Hydroperoxide Levels
- Reduced Hypercholesterolemia
- Reduced Hypercholesterolemia Incidence
- Reduced Hyperlipidemia Symptoms
- Reduced ICAM-1 Level
- Reduced Insulin Sensitivity
- Reduced Insulin/IGF-1 Signaling
- Reduced LDL Cholesterol
- Reduced LDL Levels
- Reduced LDL Oxidation
- Reduced Lead Bioaccumulation
- Reduced Lipid Levels
- Reduced Lipid Oxidation
- Reduced Lipid Peroxidation
- Reduced Lipid Profiles
- Reduced Low-Density Lipoprotein Cholesterol
- Reduced Lysophosphatidylcholine Level
- Reduced Malondialdehyde Generation
- Reduced Metabolic Inflammation
- Reduced Metabolic Lipopolysaccharide-Related Inflammation
- Reduced Monocyte Adhesion
- Reduced Monocyte Chemoattractant Protein-1 Level
- Reduced Morbidity Rate
- Reduced Mortality Rate
- Reduced Mortality from Frailty
- Reduced Myeloperoxidase Activity
- Reduced Myocardial Infarct Size
- Reduced Myocardial Injury
- Reduced NADPH Oxidase Activity
- Reduced Nitrite Level
- Reduced Non-Communicable Disease Risk
- Reduced Non-High-Density Lipoprotein Cholesterol
- Reduced Nuclear Factor Erythroid 2-Related Factor 2 Level
- Reduced Nuclear Factor Kappa-B Level
- Reduced Obesity-Related Microbial Taxa
- Reduced Obesity-Related Taxa
- Reduced Omega-6 to Omega-3 Ratio
- Reduced Oxidative Stress
- Reduced Oxidative Stress Index
- Reduced Oxidative Stress Marker Level
- Reduced Oxidative Tissue Injury
- Reduced Oxidized Glutathione Level
- Reduced Oxidized Low-Density Lipoprotein Level
- Reduced Plant Sterols
- Reduced Plaque
- Reduced Plasma CRP Levels
- Reduced Plasma Cholesterol Levels
- Reduced Plasma Homocysteine Levels
- Reduced Platelet Function Marker Level
- Reduced Post-Exercise Serum Amyloid A Increase
- Reduced Postprandial Glycemic Response
- Reduced Postprandial Triacylglycerol Response
- Reduced Postprandial Triglyceride Level
- Reduced Pre-eclampsia
- Reduced Proinflammatory Signaling
- Reduced Protein Oxidation
- Reduced Reactive Oxygen Species Formation
- Reduced Risk of COVID-19 Progression
- Reduced SCD1 Activity
- Reduced Sagittal Abdominal Diameter
- Reduced Saturated Fatty Acids in Breast Meat
- Reduced Senescence-Associated Secretory Phenotype
- Reduced Serious Adverse Events
- Reduced Serum 8-isoprostane Concentrations
- Reduced Serum Carboxymethyl-Lysine Levels
- Reduced Serum Cholesterol Levels
- Reduced Serum Glycerophospholipid Levels
- Reduced Serum Inflammatory Cytokines
- Reduced Serum LDL Levels
- Reduced Serum Lipid Levels
- Reduced Serum Plasminogen Activator Inhibitor-1
- Reduced Serum Total Cholesterol Levels
- Reduced Serum Triglycerides
- Reduced Soluble CD14
- Reduced Soluble Receptor of Advanced Glycation End Product Level
- Reduced Sugar-Sweetened Beverage Intake
- Reduced Symptoms Associated with High-Fat Diet
- Reduced TBARS Levels
- Reduced Thrombosis
- Reduced Thromboxane A2 Level
- Reduced Total Cholesterol Levels
- Reduced Triglyceride Levels
- Reduced Triglycerides
- Reduced Trimethylamine N-oxide Levels
- Reduced Trypanosoma cruzi Parasitaemia
- Reduced Type 2 Diabetes Symptoms
- Reduced Urinary 8-Isoprostane Level
- Reduced Vascular Damage
- Reduced Vascular Endothelial Growth Factor Level
- Reduced Vascular Stiffness
- Reduced Very Low-Density Lipoprotein
- Reduced Visceral Fat
- Reduced Visceral Fat Accumulation
- Reduced Visceral Fat Mass
- Reduced Visfatin Level
- Reduced Waist Circumference
- Reduced Waist-to-Height Ratio
- Reduced Yolk Cholesterol Content
- Reduced hsCRP Level
- Regulated Blood Lipid Levels
- Regulated Lipid Metabolism
- Restored HDL Levels
- Restored Lipid Metabolism
- Safe Administration
- Stabilized Cell Membranes
- Stabilized Plasma Cholesterol Levels
- Stabilized Visceral Fat Area
- Stable High-Density Lipoprotein Cholesterol Level
- Supported Physiological Function in Elderly
- Suppressed PPAR/SREBP Pathway Gene Activity
- Unchanged Plasma Lipid Levels